Shares of EverQuote surged 7.2% to $19.26 on June 4, snapping back from a sharp 5.6% selloff the day prior, as investors who sold into the post-earnings rally reconsidered a quarter that beat expectations on every metric. The tug-of-war reflects a deeper question: whether this small online insurance marketplace — just 356 employees — can sustain a trajectory toward its stated $1 billion revenue goal without acquisitions.
A Clean Beat That Investors First Bought, Then Doubted
Q1 revenue hit $190.9 million, up 15% year-over-year , significantly above the forecast of $180.15 million.
Earnings per share came in at $0.51, beating estimates by nearly 16%.
Net income more than doubled to $18.7 million from $8 million a year ago. Yet the stock initially surged after the May 4 report, rallied 36.6% over four weeks, then gave back gains aggressively — a classic pattern where latecomers get burned buying the runup.
Profit Margins Are Expanding, Not Just Revenue
Adjusted EBITDA — a rough measure of operating profit before accounting quirks — reached a record $29.3 million, reflecting improved profitability and operating leverage.
Variable marketing margin ticked up to 29.3% from 28.1%, helped by better traffic optimization. That efficiency gain matters: EverQuote essentially buys consumer insurance-shopping traffic online and resells it to carriers. Even small margin improvements on $190 million in revenue compound quickly.
Big Carriers Still Have Room to Spend More
Management noted all major carriers are actively participating, and 80% of the top 25 carriers are still below their peak spending levels , implying meaningful headroom. The company reiterated its goal of reaching $1 billion in annual revenue within 2–3 years through purely organic growth, while guiding Q2 revenue to $185–$195 million, representing 21% year-over-year growth at the midpoint.
Buybacks and Cash Signal Confidence — But the Stock Remains Volatile
EverQuote repurchased 1.1 million shares for approximately $19.9 million in Q1 , drawing from a $50 million inaugural buyback program.
The company ended March with $178.5 million in cash and zero debt.
Wall Street's consensus remains "Buy" with an average price target of $25.83 — roughly 34% above today's price. But with a 52-week range spanning $13.88 to $28.73 , shareholders should expect continued swings as the market tests whether execution can match ambition.